NEU 6.41% $15.27 neuren pharmaceuticals limited

Ann: Phase 3 enrolment successfully completed, results in Q4 2021, page-28

  1. 871 Posts.
    lightbulb Created with Sketch. 243
    Dont spread this sort of misinformation. It only leads to disappointment. P3 is NOT "a month away". The last patient enrolled in a 12 week trial today. Results will just sneak into calendar 2021 which in the circumstances is a brilliant result.
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.